Top Research Archives - PsychPartners

Dextromethorphan for SSRI-Resistant OCD

Antidepressants Medications OCD Research Top Research

Dextromethorphan for SSRI-Resistant OCD

May 11, 2026by Chris Aiken, MD0

CBT Helps Sustain Esketamine

Depression Difficult to Treat Depression Ketamine Research Therapy Top Research

CBT Helps Sustain Esketamine

May 7, 2026by Chris Aiken, MD0

A GLP-1 Trial Changes the Score in Alcohol

Alcohol GLP1 Agonists Medications Research Research for the Public Substance Use Top Research

A GLP-1 Trial Changes the Score in Alcohol

May 5, 2026by Chris Aiken, MD0

Auvelity Approved for Agitation in Dementia

Dementia Research Top Research

Auvelity Approved for Agitation in Dementia

May 1, 2026by Chris Aiken, MD0

An Off-Label Take on Dextromethorphan for Agitation in Dementia

Dementia Research Top Research

An Off-Label Take on Dextromethorphan for Agitation in Dementia

May 1, 2026by Chris Aiken, MD0

Melatonin-Ashwagandha Combination for Sleep

Hypnotics Research Research for the Public Sleep Supplements Top Research

Melatonin-Ashwagandha Combination for Sleep

April 29, 2026by Chris Aiken, MD0

Naltrexone-Baclofen Combo for Alcohol Craving

Addiction Meds Alcohol Medications Research Substance Use Top Research

Naltrexone-Baclofen Combo for Alcohol Craving

April 28, 2026by Chris Aiken, MD1

Ketamine and Liver Risk: How Worried Should You Be?

Depression Difficult to Treat Depression Ketamine Medications Side Effects Top Research

Ketamine and Liver Risk: How Worried Should You Be?

April 22, 2026by Chris Aiken, MD0

tDCS for Treatment-Resistant Depression

Depression Difficult to Treat Depression Research Research for the Public Top Research

tDCS for Treatment-Resistant Depression

April 6, 2026by Chris Aiken, MD0

Mirtazapine Reduces Meth Use

Addiction Meds Methamphetamine Research Top Research

Mirtazapine Reduces Meth Use

April 2, 2026by Chris Aiken, MD2

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

Antipsychotics Research Schizophrenia and Psychosis Top Research

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

March 30, 2026by Chris Aiken, MD3

Quetiapine vs Lithium for Treatment-Resistant Depression

Antipsychotics Depression Difficult to Treat Depression Lithium Research Top Research

Quetiapine vs Lithium for Treatment-Resistant Depression

March 23, 2026by Chris Aiken, MD0

Dextromethorphan Helps When Clozapine Fails in Schizophrenia

Antipsychotics Clozapine Research Schizophrenia and Psychosis Top Research

Dextromethorphan Helps When Clozapine Fails in Schizophrenia

March 18, 2026by Chris Aiken, MD5

Flow: At-home tDCS Approved for Depression

Depression Neuromodulation/TMS Research Research for the Public Top Research

Flow: At-home tDCS Approved for Depression

March 17, 2026by Chris Aiken, MD0

Hot Yoga for Depression

Depression Exercise Lifestyle Research Research for the Public Top Research

Hot Yoga for Depression

March 16, 2026by Chris Aiken, MD0

A Wearable Headset for Difficult-to-Treat Depression

Depression Devices Difficult to Treat Depression Neuromodulation/TMS Research Research for the Public Top Research

A Wearable Headset for Difficult-to-Treat Depression

March 15, 2026by Chris Aiken, MD0

When to Stop: An Expert Consensus on Deprescribing Psychotropics

Deprescribing Geriatric Psychiatry Medications Research Top Research

When to Stop: An Expert Consensus on Deprescribing Psychotropics

March 11, 2026by Chris Aiken, MD0

Do ADHD Meds Cause Tolerance?

ADHD Medications Research Research for the Public Stimulants Top Research

Do ADHD Meds Cause Tolerance?

February 2, 2026by Chris Aiken, MD0

Two GLP-1 Agonists Fail in Dementia

Dementia GLP1 Agonists Research Top Research

Two GLP-1 Agonists Fail in Dementia

January 25, 2026by Chris Aiken, MD0

Semaglutide (Ozempic) in Depression

Cognition Depression GLP1 Agonists Research Research for the Public Top Research

Semaglutide (Ozempic) in Depression

December 5, 2025by Chris Aiken, MD0